Stina Syvänen

Title: Stina Syvänen: Innovator in Brain Delivery Proteins

Introduction

Stina Syvänen is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of brain delivery proteins. Her innovative work aims to enhance therapeutic approaches for neurodegenerative disorders and other brain diseases.

Latest Patents

Stina Syvänen holds a patent for a brain delivery protein. This invention comprises a target binding antibody that binds to a target in a mammalian brain. It includes two carrier moieties, each capable of monovalent interaction with a protein expressed on a blood-brain barrier (BBB) endothelial cell. Each carrier moiety is linked to the C-terminal end of the target binding antibody. The patent also covers the use of such brain delivery proteins in therapy, diagnosis, or research related to neurodegenerative disorders and other brain diseases.

Career Highlights

Stina Syvänen is associated with Bioarctic AB, a company focused on developing innovative treatments for neurodegenerative diseases. Her work at Bioarctic has positioned her as a key figure in the biotechnology sector, contributing to advancements in brain-targeted therapies.

Collaborations

Stina has collaborated with notable colleagues, including Lars Lannfelt and Dag Sehlin. These partnerships have furthered her research and development efforts in the field of brain delivery systems.

Conclusion

Stina Syvänen's contributions to the field of brain delivery proteins exemplify her commitment to advancing medical science. Her innovative patent and work at Bioarctic AB highlight her role as a leading inventor in biotechnology.